Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Clinical Pharmacokinetics of Novel Biopharmaceuticals
*Corresponding Author:Received Date: Jun 04, 2024 / Published Date: Jun 28, 2024
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Abstract:
Biopharmaceuticals, including monoclonal antibodies, fusion proteins, and therapeutic peptides, have emerged as pivotal therapies in modern medicine due to their targeted efficacy and reduced side effects compared to traditional drugs. Understanding their clinical pharmacokinetics is crucial for optimizing therapeutic outcomes and ensuring patient safety. This review explores the absorption, distribution, metabolism, and excretion (ADME) of novel biopharmaceuticals, highlighting factors influencing their pharmacokinetic profiles and clinical implications. Insights into biopharmaceutical pharmacokinetics inform dosing strategies, therapeutic monitoring, and the development of personalized medicine approaches
